Use access key #2 to skip to page content.
$53.80 5.22 (10.75%)
10/13/2008 4:00 PM

Amgen, Inc. (AMGN)

CAPS Rating:
****

A biotechnology company whcih discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology.

View All Commentary (AMGN)

Recs

7

Avatar gstrout (< 20) Submitted: 6/17/06 7:59 PM : Outperform Start Price: $67.14 AMGN Score: 8.46

Proven ability to bring innovative therapies to market, solid financials, several strong revenue generating therapies in the market, a deep pipeline, heavy R&D spending, 3-4 mid-to-late stage products with good potential, and a price drop thanks to market gravity and... I'm in.

Report this Post Replies: 0 | Reply

Featured Broker Partners